Zobrazeno 1 - 10 of 1 347 pro vyhledávání: '"Wilker, E."'
1
Mulher e critíca (a propósito de Maria Wilker e outras)
Autor: Averbuck, Ligia
Publikováno v: Signo; v. 10 n. 16 (1985)
Signo (Santa Cruz do Sul. Online)
Universidade de Santa Cruz do Sul (UNISC)
instacron:UNISC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::e2e9c2dd1a9b527bbe062bf64b0f44e1
https://online.unisc.br/seer/index.php/signo/article/view/9098
Zobrazit plný text záznamu
2
Akademický článek
FT-4202, a selective pyruvate kinase R activator for sickle cell disease.
Autor: Ericsson A; Forma Therapeutics, Inc., Watertown, MA., Richard DJ; Forma Therapeutics, Inc., Watertown, MA., Wilker E; Forma Therapeutics, Inc., Watertown, MA., Lancia DR Jr; Forma Therapeutics, Inc., Watertown, MA., Fessler S; Forma Therapeutics, Inc., Watertown, MA., Troccolo P; Forma Therapeutics, Inc., Watertown, MA., Zheng X; Forma Therapeutics, Inc., Watertown, MA., Toms A; Forma Therapeutics, Inc., Watertown, MA., Dinsmore C; Forma Therapeutics, Inc., Watertown, MA., Yao L; Forma Therapeutics, Inc., Watertown, MA., Kuypers FA; University of California San Francisco, Oakland, CA., Larkin S; University of California San Francisco, Oakland, CA., Marcotte D; Forma Therapeutics, Inc., Watertown, MA., Fulzele K; Forma Therapeutics, Inc., Watertown, MA., Ribadeneira M; Forma Therapeutics, Inc., Watertown, MA., Guichard SM; Novo Nordisk, Watertown, MA. Electronic address: sygx@novonordisk.com., Marshall G; Forma Therapeutics, Inc., Watertown, MA.
Publikováno v: Experimental hematology [Exp Hematol] 2024 Nov 15, pp. 104673. Date of Electronic Publication: 2024 Nov 15.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Lipid and endothelium-related genes, ambient particulate matter, and heart rate variability—the VA Normative Aging Study
Autor: Ren, C, Baccarelli, A, Wilker, E, Suh, H, Sparrow, D, Vokonas, P, Wright, R, Schwartz, J
Publikováno v: Journal of Epidemiology and Community Health (1979-), 2010 Jan 01. 64(1), 49-56.
Externí odkaz: https://www.jstor.org/stable/20721131
Zobrazit plný text záznamu
6
Deep structures seismic enhancement using singular spectral analysis in time and frequency domain: Application in the regional transect of Parnaíba basin - Brazil
Autor: Rafael R. Manenti, Wilker E. Souza, Milton J. Porsani
Publikováno v: Journal of Applied Geophysics. 164:19-25
The Parnaiba basin is located in the Northeast of Brazil and it started in the Archaean . In a project involving Global Geophysical Services Incorporated and BP Energy do Brasil, a 2D seismic data , 1400 km long and 20 s of two-way travel time was ac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce1bb04720d324e9416f9d8f36a4c47c
https://doi.org/10.1016/j.jappgeo.2019.02.020
Zobrazit plný text záznamu
7
Akademický článek
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer.
Autor: Caligiuri M; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Williams GL; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Castro J; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Battalagine L; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Wilker E; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Yao L; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Schiller S; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Toms A; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Li P; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Pardo E; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Graves B; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Azofeifa J; Arpeggio Bio, Boulder, CO, USA., Chicas A; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Herbertz T; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Lai M; Arpeggio Bio, Boulder, CO, USA., Basken J; Arpeggio Bio, Boulder, CO, USA., Wood KW; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Xu Q; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA., Guichard SM; Forma Therapeutics, Inc, 300 N Beacon St, Watertown, MA, 02472, USA. sguichard@formatherapeutics.com.
Publikováno v: Targeted oncology [Target Oncol] 2023 Mar; Vol. 18 (2), pp. 269-285. Date of Electronic Publication: 2023 Feb 24.
Zobrazit plný text záznamu
8
Akademický článek
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.
Autor: Simoneau A; Tango Therapeutics, Boston, Massachusetts., Engel JL; Tango Therapeutics, Boston, Massachusetts., Bandi M; Tango Therapeutics, Boston, Massachusetts., Lazarides K; Tango Therapeutics, Boston, Massachusetts., Liu S; Tango Therapeutics, Boston, Massachusetts., Meier SR; Tango Therapeutics, Boston, Massachusetts., Choi AH; Tango Therapeutics, Boston, Massachusetts., Zhang H; Tango Therapeutics, Boston, Massachusetts., Shen B; Tango Therapeutics, Boston, Massachusetts., Martires L; Tango Therapeutics, Boston, Massachusetts., Gotur D; Tango Therapeutics, Boston, Massachusetts., Pham TV; Tango Therapeutics, Boston, Massachusetts., Li F; Tango Therapeutics, Boston, Massachusetts., Gu L; Tango Therapeutics, Boston, Massachusetts., Gong S; Tango Therapeutics, Boston, Massachusetts., Zhang M; Tango Therapeutics, Boston, Massachusetts., Wilker E; Tango Therapeutics, Boston, Massachusetts., Pan X; Tango Therapeutics, Boston, Massachusetts., Whittington DA; Tango Therapeutics, Boston, Massachusetts., Throner S; Tango Therapeutics, Boston, Massachusetts., Maxwell JP; Tango Therapeutics, Boston, Massachusetts., Chen Y; Tango Therapeutics, Boston, Massachusetts., Yu Y; Tango Therapeutics, Boston, Massachusetts., Huang A; Tango Therapeutics, Boston, Massachusetts., Andersen JN; Tango Therapeutics, Boston, Massachusetts., Feng T; Tango Therapeutics, Boston, Massachusetts.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Feb 01; Vol. 22 (2), pp. 215-226.
Zobrazit plný text záznamu
10
Akademický článek
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma.
Autor: Shields JA; Tango Therapeutics, Boston, Massachusetts., Meier SR; Tango Therapeutics, Boston, Massachusetts., Bandi M; Tango Therapeutics, Boston, Massachusetts., Mulkearns-Hubert EE; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Hajdari N; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Ferdinez MD; Tango Therapeutics, Boston, Massachusetts., Engel JL; Tango Therapeutics, Boston, Massachusetts., Silver DJ; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Shen B; Tango Therapeutics, Boston, Massachusetts., Zhang W; Tango Therapeutics, Boston, Massachusetts., Hubert CG; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Mitchell K; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Shakya S; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Zhao SC; Tango Therapeutics, Boston, Massachusetts., Bejnood A; Tango Therapeutics, Boston, Massachusetts., Zhang M; Tango Therapeutics, Boston, Massachusetts., Tjin Tham Sjin R; Tango Therapeutics, Boston, Massachusetts., Wilker E; Tango Therapeutics, Boston, Massachusetts., Lathia JD; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Andersen JN; Tango Therapeutics, Boston, Massachusetts., Chen Y; Tango Therapeutics, Boston, Massachusetts., Li F; Tango Therapeutics, Boston, Massachusetts., Weber B; Tango Therapeutics, Boston, Massachusetts., Huang A; Tango Therapeutics, Boston, Massachusetts., Emmanuel N; Tango Therapeutics, Boston, Massachusetts.
Publikováno v: Cancer research [Cancer Res] 2022 Nov 02; Vol. 82 (21), pp. 4044-4057.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje